Latest data from June 17, 2022
Number of Health Center respondents = 19 (83% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 3,491 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 77.40% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 719 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 81.27% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 17.47% | 14.74% |
White, Hispanic/Latino Patients | 32.91% | 35.74% |
Black/African American, Non-Hispanic/Latino Patients | 3.01% | 2.09% |
Black/African American, Hispanic/Latino Patients | 0.26% | 0.28% |
Asian Patients3 | 0.83% | 0.83% |
American Indian/Alaska Native Patients3 | 5.44% | 7.37% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.20% | 0.42% |
Patients with More Than One Race3 | 7.59% | 6.82% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 9.60% | 10.43% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.38% | 1.81% |
Unreported/Refused to Report Race and Ethnicity | 18.30% | 19.47% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 730 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 84.96% |
COVID-19 Immunization Series Completed | 437 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 83.83% |
COVID-19 Immunization Series Additional | 2,149 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 74.76% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 13.29% | 12.36% | 20.43% |
White, Hispanic/Latino Patients | 49.18% | 40.05% | 39.13% |
Black/African American, Non-Hispanic/Latino Patients | 8.49% | 4.12% | 2.56% |
Black/African American, Hispanic/Latino Patients | 0.55% | 0.69% | 0.28% |
Asian Patients3 | 1.92% | 0.69% | 0.56% |
American Indian/Alaska Native Patients3 | 2.05% | 2.06% | 1.02% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.14% | 0.23% | 0.09% |
Patients with More Than One Race3 | 1.10% | 5.72% | 9.17% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 11.64% | 10.53% | 7.68% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.05% | 9.61% | 1.86% |
Unreported/Refused to Report Race and Ethnicity | 9.59% | 13.96% | 17.22% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 10.53% |
1 to 24 Hours | 42.11% |
More Than 24 Hours | 47.37% |
N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 5.26% |
Staffing to administer the vaccine | 42.11% |
Vaccine confidence | 21.05% |
Vaccine storage capacity | 0.00% |
Vaccine supply | 0.00% |
Other | 5.26% |
None | 36.84% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 15.79% |
Average Percent of Health Center Visits Conducted Virtually | 16.05% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 26.32% |
Number of Mobile Van Sites | 7 |
Number of Pop-up Clinics | 6 |
Number of School-Based Vaccination Sites | 0 |
Number of Family Vaccination Clinics | 12 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 0.00% |
Refer patients to another organization that provides monoclonal antibody therapies | 42.11% |
None | 57.89% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 10.53% |
Patient awareness/education | 10.53% |
Staffing capacity | 26.32% |
Therapy administration/onsite logistics | 21.05% |
Other | 5.26% |
None | 42.11% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 15 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 4,514 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 93.33% |
Provided to General Public Who Came to the Health Center | 73.33% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 20.00% |
Provided at Other Community Events | 33.33% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 13.33% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 13.33% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 6.67% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 6.67% |
Other | 6.67% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 8 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 5,627 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 100.00% |
Provided to General Public Who Came to the Health Center | 62.50% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 25.00% |
Provided at Other Community Events | 37.50% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 25.00% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 25.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 5 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 56.07% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 18.22% |
White, Hispanic/Latino Patients | 35.98% |
Black/African American, Non-Hispanic/Latino Patients | 4.67% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 0.00% |
American Indian/Alaska Native Patients3 | 3.27% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
Patients with More Than One Race3 | 0.93% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 11.21% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.93% |
Unreported/Refused to Report Race and Ethnicity | 24.77% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 0.93% |
Patients Experiencing Homelessness | 0.47% |
Patients Who Are Residents of Public Housing | 3.27% |
Patients with Limited English Proficiency | 6.07% |
Children Under 18 Years of Age | 0.93% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.